DaVita
DVA
#1459
Rank
ยฃ9.52 B
Marketcap
ยฃ116.17
Share price
-2.01%
Change (1 day)
37.67%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

Revenue for DaVita (DVA)

Revenue in 2024 (TTM): ยฃ9.85 Billion

According to DaVita's latest financial reports the company's current revenue (TTM ) is ยฃ9.97 Billion. In 2023 the company made a revenue of ยฃ9.52 Billion a decrease over the revenue in the year 2022 that were of ยฃ9.59 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for DaVita from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ9.85 B3.45%
2023 ยฃ9.52 B-0.7%
2022 ยฃ9.59 B11.49%
2021 ยฃ8.60 B1.58%
2020 ยฃ8.47 B-2.43%
2019 ยฃ8.68 B-3.34%
2018 ยฃ8.98 B11.64%
2017 ยฃ8.04 B-27.67%
2016 ยฃ11.12 B19.64%
2015 ยฃ9.29 B13.16%
2014 ยฃ8.21 B15.23%
2013 ยฃ7.13 B41.69%
2012 ยฃ5.03 B14.31%
2011 ยฃ4.40 B5.46%
2010 ยฃ4.17 B10.6%
2009 ยฃ3.77 B-2.25%
2008 ยฃ3.86 B45.75%
2007 ยฃ2.64 B6.34%
2006 ยฃ2.49 B49.26%
2005 ยฃ1.66 B39.42%
2004 ยฃ1.19 B4.66%
2003 ยฃ1.14 B-1.1%
2002 ยฃ1.15 B1.59%
2001 ยฃ1.13 B14.33%
2000 ยฃ0.99 B11.34%
1999 ยฃ0.89 B23.43%
1998 ยฃ0.72 B127.95%
1997 ยฃ0.31 B99.53%
1996 ยฃ0.15 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ16.50 B 65.57%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.57 B-84.16%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ12.13 B 21.72%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ10.00 B 0.36%๐Ÿ‡บ๐Ÿ‡ธ USA